Exercise and/or psychological interventions effectively reduce cancer-related fatigue during and after cancer treatment.
In this study, researchers sought to identify physical, neurocognitive, and serologic markers that may correlate with self-reported fatigue before and after (neo)adjuvant chemotherapy for patients with early-stage breast cancer.
Severe fatigue is associated with unemployment and financial problems in survivors of Hodgkin lymphoma, highlighting the need for clinicians to address fatigue in these patients.
Infrared laser moxibustion, an infrared laser treatment combined with a traditional acupuncture modality, appears safe and effective in relieving cancer-related fatigue.
Relaxing acupressure resulted in significant improvement in persistent fatigue, sleep quality, and quality of life among survivors of breast cancer, a recent study has shown.
Oral melatonin at a dose of 20 mg was not associated with improvement in fatigue or other symptoms in patients with advanced cancer.
Treatment with the traditional Chinese medicine herbal mixture helped relieve fatigue in cancer patients, according to trial data.
Music therapy improves anxiety, depression, pain, and fatigue in patients with cancer.
Oncology fellows may underestimate future workload of actual practice.
Recent studies show the evidence continues to support exercise and holistic measures as the most effective intervention for cancer-related fatigue.
Fatigue is a debilitating problem for cancer patients undergoing treatment, and it also can significantly affect quality of life after treatment.
Chemotherapy disrupts circadian rhythms leading to a higher risk for clinically relevant fatigue or weight loss.
The central nervous system stimulant modafinil is not effective in treating non-small-cell lung cancer-related fatigue, according to a study.
Cognitive behavioral therapy can help patients with breast cancer undergoing radiotherapy to manage fatigue, often their most debilitating side effect.
Chemotherapy, one of the major treatments for breast cancer, can leave a long-lasting epigenetic imprint in the DNA of the blood cells of breast cancer patients, according to new research.
Breast cancer patients receiving radiotherapy showed decreased fatigue as a result of cognitive behavioral therapy plus hypnosis, according to a new study.
A new study explores how cancer-related fatigue affects some patients more than others and is trying to determine the nature of that difference.
Chronic fatigue is more than three times more prevalent among adult survivors of childhood leukemia or lymphoma than among other adults.
Protocolized patient-tailored treatment of physical symptoms improves fatigue in advanced cancer.
A new immunomodulatory drug under FDA review significantly increased survival in persons with multiple myeloma, including older patients.
The FDA has expanded the indication for abiraterone acetate (Zytiga tablets) to combat metastatic castration-resistant prostate cancer.
The final data from a phase II study confirmed the high degree of activity of quizartinib in persons with acute myeloid leukemia.
Ibrutinib, which targets the Bruton's tyrosine kinase to combat chronic lymphocytic leukemia, showed promising results in two phase II studies.
How long is considered normal for patients to still experience fatigue, and do they need additional follow-up?
Over the trajectory of chemotherapy treatment, school-age children appear to develop resilience to fatigue.
Improvements also seen in quality of life after six weeks of treatment.
Breast cancer survivors who develop such behavioral skills as self-confidence and motivation are much more likely to continue exercising on their own after leaving a supervised exercise program.
No relief for patients with invasive malignancies given L-carnitine supplementation 2 g/day for four weeks.
Women with breast cancer have many treatment options. This patient fact sheet details the side effects of these treatments and ways to cope.
Fatigue, anxiety, and quality of life improve for participating disease-free cancer survivors.
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- CQGS Releases Standards for Surgical Care of Older Adults
- Radiation Protocol Deviations Linked to Worse Outcomes in Pediatric Brain Malignancy
- Use of Counseling, Surgery Rates Show Limited Physician Knowledge of Breast Cancer Genetic Testing
- Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|